comparemela.com

Japanese Foundation For Cancer Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Inside the Japanese royal family tree – the Imperial House explained

Inside the Japanese royal family tree – the Imperial House explained
hellomagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hellomagazine.com Daily Mail and Mail on Sunday newspapers.

How Adiponectin Sends The Starvation Signal To The Brain

A fat-derived protein known for its effects on the liver and skeletal muscle might also serve as an energy-conserving signal to the brain during periods of starvation, suggests a new study.

Parexel and Japanese Foundation for Cancer Research

Nels Lippert - IPWatchdog com | Patents & Intellectual Property Law

Nels Lippert is a partner and chair of Tarter, Krinsky & Drogin’s Intellectual Property Practice. Nels has more than 40 years of experience focusing on intellectual property counseling and litigation. Nels administers trademarks globally for leading U.S. and international consumer product manufacturers, online and retail fashion companies, software and systems providers, and service companies. He regularly represents clients’ trademark interests…

Risk-reducing decisions regarding germline BRCA pathogenic variant: focusing on the timing of genetic testing and RRSO

Background In Japan, the public insurance policy was revised in 2020 to cover hereditary breast and ovarian cancer (HBOC), including genetic testing and surveillance, for patients with breast cancer (BC). Consequently, the demand for risk-reducing salpingo-oophorectomy (RRSO) has increased. This study aimed to clarify the changes in the demand and timing of genetic testing and RRSO associated with public insurance coverage for HBOC in Japan. Methods This retrospective analysis included 350 women with germline BRCA (g BRCA ) pathogenic variants (PVs) who had visited gynaecologists; they received g BRCA genetic testing at 45.1±10.6 (20–74) years. The use of medical testing and preventive treatment was compared between the preinsurance and postinsurance groups using Mann-Whitney U and Fisher’s exact tests. Results The findings indicate that RRSO rates doubled from 31.4% to 62.6% among patients with g BRCA -PV. The implementation rate was 32.4% among unaffected carriers and 70.3%

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.